Skip to main content
. 2022 Nov;23(11):3947–3952. doi: 10.31557/APJCP.2022.23.11.3947

Table 4.

COX Analysis of DMFS

Parameters HR (95% Cl) P value
LIMCH1 expression 5.3116 (2.5356; 11.1267) 0.00001
presence vs absence
Limphogenous metastases: 712 (1.9516; 9.3480) 0.0003
presence vs absence
NACT: 1.2302 (0.5997; 2.5237) 0.5720
presence vs absence
N: 1.5921 (0.1957; 12.9537) 0.5407
N3 vs N0 3.5506 (0.4241; 12.9537) 0.1244
N2 vs N0 3.4130 (0.5154; 22.6008) 0.5438
N1 vs N0
Grade: 0.9921 (0.3391; 2.9025) 0.9884
3 vs 2
T: 3.6937 (1.7557; 7.7707) 0.0006
T3-4 vs T1-2
Tumor size: 2.7302 (0.7170; 10.3957) 0.0797
>50 mm vs <20 mm 1.0017 (0.3623; 2.7690) 0.2392
20– 50 mm vs <20 mm
Menstrual status: 0.5976 (0.2767; 1.2908) 0.1901
Menopause vs pre-menopause
Age: 0.4583 (0.1531; 1.3716) 0.2334
>50 vs <35 0.5219 (0.1651; 1.6498) 0.5281
35-50 vs <35